cAMP induces CD14 expression in murine macrophages via increased transcription

CD14, a glycoprotein that binds bacterial lipopolysaccharide, plays a critical role in the inflammatory response to infection by gram‐negative bacteria. Studies were undertaken to determine whether cyclic adenosine monophosphate (cAMP) regulates CD14 expression in macrophages. Incubation of RAW 264.7 cells with 8‐Br‐cAMP resulted in a significant increase in steady‐state CD14 mRNA levels. The increase in mRNA levels was also associated with both cell‐associated and soluble CD14 protein. H89 completely blocked the 8‐Br‐cAMP‐induced CD14 mRNA up‐regulation. There was no change in CD14 mRNA half‐life in the presence of 8‐Br‐cAMP. The CD14 gene transcription rate was increased about twofold after exposure to 8‐Br‐cAMP. cAMP‐dependent increases in CD14 mRNA were also observed in rat peritoneal macrophages, demonstrating that this is an authentic response of mature macrophages. This study provides evidence that cAMP and protein kinase A are important regulators of CD14 expression in macrophages. J. Leukoc. Biol. 67: 894–901; 2000.

[1]  B. Monks,et al.  Membrane Expression of Soluble Endotoxin-binding Proteins Permits Lipopolysaccharide Signaling in Chinese Hamster Ovary Fibroblasts Independently of CD14* , 1999, The Journal of Biological Chemistry.

[2]  F. Gusovsky,et al.  Toll-like Receptor-4 Mediates Lipopolysaccharide-induced Signal Transduction* , 1999, The Journal of Biological Chemistry.

[3]  P. Ricciardi-Castagnoli,et al.  Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutations in Tlr4 gene. , 1998, Science.

[4]  M. Rothe,et al.  Human Toll-like Receptor 2 Confers Responsiveness to Bacterial Lipopolysaccharide , 1998, The Journal of experimental medicine.

[5]  E. Muñoz-Elías,et al.  Vasoactive Intestinal Peptide and Pituitary Adenylate Cyclase-activating Polypeptide Inhibit Tumor Necrosis Factor α Transcriptional Activation by Regulating Nuclear Factor-kB and cAMP Response Element-binding Protein/c-Jun* , 1998, The Journal of Biological Chemistry.

[6]  S. Morris,et al.  Differential regulation of arginases and inducible nitric oxide synthase in murine macrophage cells. , 1998, American journal of physiology. Endocrinology and metabolism.

[7]  Simon C Watkins,et al.  Expression of CD14 by Hepatocytes: Upregulation by Cytokines during Endotoxemia , 1998, Infection and Immunity.

[8]  B. Roe,et al.  Genetic and physical mapping of the Lps locus: identification of the toll-4 receptor as a candidate gene in the critical region. , 1998, Blood cells, molecules & diseases.

[9]  M. Foti,et al.  CD14-dependent Endotoxin Internalization via a Macropinocytic Pathway* , 1998, The Journal of Biological Chemistry.

[10]  G. Hartmann,et al.  Adrenaline enhances LPS-induced IL-10 synthesis: evidence for protein kinase A-mediated pathway. , 1998, International journal of immunopharmacology.

[11]  M. Tremblay,et al.  Prostaglandin E2 induces resistance to human immunodeficiency virus-1 infection in monocyte-derived macrophages: downregulation of CCR5 expression by cyclic adenosine monophosphate. , 1998, Blood.

[12]  I. Bérczi.  Neurohormonal Host Defense in Endotoxin Shock , 1998, Annals of the New York Academy of Sciences.

[13]  Xian Wang,et al.  Calcitonin gene-related peptide potentiates LPS-induced IL-6 release from mouse peritoneal macrophages , 1998, Journal of Neuroimmunology.

[14]  G. López-Lluch,et al.  Redox regulation of cAMP levels by ascorbate in 1,25-dihydroxy- vitamin D3-induced differentiation of HL-60 cells. , 1998, The Biochemical journal.

[15]  C. Fearns,et al.  EFFECT OF RECOMBINANT INTERLEUKIN‐1β ON MURINE CD14 GENE EXPRESSION IN VIVO , 1998, Shock.

[16]  R. Schumann,et al.  Lipopolysaccharide and pneumococcal cell wall components activate the mitogen activated protein kinases (MAPK) erk‐1, erk‐2, and p38 in astrocytes , 1998, Glia.

[17]  L. Kline,et al.  Cell Activation Mediated by Glycosylphosphatidylinositol-Anchored or Transmembrane Forms of CD14 , 1998, Infection and Immunity.

[18]  S. Mustafa,et al.  Expression of Nitric-oxide Synthase in Rat Kupffer Cells Is Regulated by cAMP* , 1998, The Journal of Biological Chemistry.

[19]  M. Bukrinsky,et al.  Relative Contribution of Transcription and Translation to the Induction of Tumor Necrosis Factor-α by Lipopolysaccharide* , 1998, The Journal of Biological Chemistry.

[20]  S. Endres,et al.  Anti‐inflammatory activities of cAMP‐elevating agents: enhancement of IL‐10 synthesis and concurrent suppression of TNF production , 1998, Journal of leukocyte biology.

[21]  R. Landmann,et al.  Human monocyte CD14 is upregulated by lipopolysaccharide , 1996, Infection and immunity.

[22]  P. Schlag,et al.  Lipopolysaccharide induces the rapid tyrosine phosphorylation of the mitogen-activated protein kinases erk-1 and p38 in cultured human vascular endothelial cells requiring the presence of soluble CD14. , 1996, Blood.

[23]  H. Engelmann,et al.  The myeloid differentiation antigen CD14 is N- and O-glycosylated. Contribution of N-linked glycosylation to different soluble CD14 isoforms. , 1996, European journal of biochemistry.

[24]  T. van der Poll,et al.  Epinephrine inhibits tumor necrosis factor-alpha and potentiates interleukin 10 production during human endotoxemia. , 1996, The Journal of clinical investigation.

[25]  G. Su,et al.  Role of lipopolysaccharide (LPS), interleukin-1, interleukin-6, tumor necrosis factor, and dexamethasone in regulation of LPS-binding protein expression in normal hepatocytes and hepatocytes from LPS-treated rats , 1995, Infection and immunity.

[26]  J. Silver,et al.  Recombinant soluble CD14 prevents mortality in mice treated with endotoxin (lipopolysaccharide). , 1995, Journal of immunology.

[27]  Y. Yoshikai,et al.  Dibutyryl cyclic AMP protects Corynebacterium parvum-treated mice against lipopolysaccharide-induced lethal toxicity. , 1995, Cellular immunology.

[28]  F. Blecha,et al.  CD14 and other recognition molecules for lipopolysaccharide: a review. , 1995, Immunopharmacology.

[29]  D. Golenbock,et al.  CD11c/CD18, a transmembrane signaling receptor for lipopolysaccharide , 1995, The Journal of experimental medicine.

[30]  B. Brüne,et al.  Nitric oxide-induced apoptosis in RAW 264.7 macrophages is antagonized by protein kinase C- and protein kinase A-activating compounds. , 1995, Molecular pharmacology.

[31]  J. Gegner,et al.  Lipopolysaccharide (LPS) Signal Transduction and Clearance , 1995, The Journal of Biological Chemistry.

[32]  M. Ernst,et al.  Endotoxin activates human vascular smooth muscle cells despite lack of expression of CD14 mRNA or endogenous membrane CD14 , 1995, Infection and immunity.

[33]  S. Chavali,et al.  Effects of prostaglandin E2, cholera toxin and 8-bromo-cyclic AMP on lipopolysaccharide-induced gene expression of cytokines in human macrophages. , 1995, Immunology.

[34]  R. Landmann,et al.  Increased circulating soluble CD14 is associated with high mortality in gram-negative septic shock. , 1995, The Journal of infectious diseases.

[35]  S. Endres,et al.  Enhanced tumor necrosis factor suppression and cyclic adenosine monophosphate accumulation by combination of phosphodiesterase inhibitors and prostanoids , 1995, European journal of immunology.

[36]  N. Reiner,et al.  CD14-dependent activation of protein kinase C and mitogen-activated protein kinases (p42 and p44) in human monocytes treated with bacterial lipopolysaccharide. , 1994, Journal of immunology.

[37]  R. Thieringer,et al.  CD14-mediated translocation of nuclear factor-kappa B induced by lipopolysaccharide does not require tyrosine kinase activity. , 1994, The Journal of biological chemistry.

[38]  A. Tomasz,et al.  CD14 is a pattern recognition receptor. , 1994, Immunity.

[39]  M. Read,et al.  Cell-free pool of CD14 mediates activation of transcription factor NF-kappa B by lipopolysaccharide in human endothelial cells. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[40]  C. June,et al.  Lipopolysaccharide-induced protein tyrosine phosphorylation in human macrophages is mediated by CD14. , 1993, Journal of immunology.

[41]  F. Liew,et al.  Nitric oxide production by murine macrophages is inhibited by prolonged elevation of cyclic AMP. , 1993, Biochemical and biophysical research communications.

[42]  J. Silver,et al.  Recombinant soluble CD14 mediates the activation of endothelial cells by lipopolysaccharide. , 1993, Journal of immunology.

[43]  W. Buurman,et al.  Involvement of CD14 in lipopolysaccharide-induced tumor necrosis factor-alpha, IL-6 and IL-8 release by human monocytes and alveolar macrophages. , 1993, Journal of immunology.

[44]  T. Kirikae,et al.  Endotoxin receptors on mammalian cells. , 1993, Immunobiology.

[45]  R. Ulevitch,et al.  Lipopolysaccharide activation of human endothelial and epithelial cells is mediated by lipopolysaccharide-binding protein and soluble CD14. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[46]  C. Hunter,et al.  Regulation of tumor necrosis factor production by adrenaline and beta-adrenergic agonists. , 1992, Journal of immunology.

[47]  M. Goldman,et al.  Lipopolysaccharide induces up‐regulation of CD14 molecule on monocytes in human whole blood , 1992, European journal of immunology.

[48]  D. Morrison,et al.  Detection and analysis of the 80‐kd lipopolysaccharide receptor in macrophages derived from Lpsn and Lpsd mice , 1992, Journal of leukocyte biology.

[49]  S. Morrison,et al.  A comparison of apparent mRNA half-life using kinetic labeling techniques vs decay following administration of transcriptional inhibitors. , 1991, Analytical biochemistry.

[50]  J. Strominger,et al.  Shedding as a mechanism of down-modulation of CD14 on stimulated human monocytes. , 1991, Journal of immunology.

[51]  M. Krieger,et al.  Recognition and plasma clearance of endotoxin by scavenger receptors , 1991, Nature.

[52]  R. Ulevitch,et al.  CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. , 1990, Science.

[53]  S. Perkins,et al.  Prostaglandin E specifically upregulates the expression of the mannose-receptor on mouse bone marrow-derived macrophages. , 1990, Cell regulation.

[54]  M. Hagiwara,et al.  Inhibition of forskolin-induced neurite outgrowth and protein phosphorylation by a newly synthesized selective inhibitor of cyclic AMP-dependent protein kinase, N-[2-(p-bromocinnamylamino)ethyl]-5-isoquinolinesulfonamide (H-89), of PC12D pheochromocytoma cells. , 1990, The Journal of biological chemistry.

[55]  D. Reinberg,et al.  Phosphorylation of cellular proteins regulates their binding to the cAMP response element. , 1989, The Journal of biological chemistry.

[56]  R. A. Atherton,et al.  Products of lipopolysaccharide-activated macrophages (tumor necrosis factor-alpha, transforming growth factor-beta) but not lipopolysaccharide modify DNA synthesis by rat trophoblast cells exhibiting the 80-kDa lipopolysaccharide-binding protein. , 1989, Journal of immunology.

[57]  R. Strieter,et al.  Dynamics of dibutyryl cyclic AMP- and prostaglandin E2-mediated suppression of lipopolysaccharide-induced tumor necrosis factor alpha gene expression , 1989, Infection and immunity.

[58]  S. Yamamoto,et al.  Mouse and human CD14 (myeloid cell-specific leucine-rich glycoprotein) primary structure deduced from cDNA clones. , 1989, Biochimica et biophysica acta.

[59]  S. Wright,et al.  CR3 (CD11b/CD18) expresses one binding site for Arg-Gly-Asp-containing peptides and a second site for bacterial lipopolysaccharide , 1989, The Journal of experimental medicine.

[60]  V. Boggaram,et al.  Transcriptional regulation of the gene encoding the major surfactant protein (SP-A) in rabbit fetal lung. , 1988, The Journal of biological chemistry.

[61]  S. Goyert,et al.  The monocyte differentiation antigen, CD14, is anchored to the cell membrane by a phosphatidylinositol linkage. , 1988, Journal of immunology.

[62]  Y. Hod,et al.  Cyclic AMP stabilizes the mRNA for phosphoenolpyruvate carboxykinase (GTP) against degradation. , 1988, The Journal of biological chemistry.

[63]  D. Remick,et al.  Prostaglandin E2 regulates macrophage-derived tumor necrosis factor gene expression. , 1988, The Journal of biological chemistry.

[64]  T. Suzuki,et al.  Prostaglandin-E2-induced activation of adenosine 3'-5' cyclic monophosphate-dependent protein kinases of a murine macrophage-like cell line (P388D1). , 1987, Journal of immunology.

[65]  S. Brandwein.  Regulation of interleukin 1 production by mouse peritoneal macrophages. Effects of arachidonic acid metabolites, cyclic nucleotides, and interferons. , 1986, The Journal of biological chemistry.

[66]  R. Katz,et al.  Studies on the methylation of avian sarcoma proviruses in permissive and non-permissive cells. , 1983, The Journal of general virology.

[67]  A. Cruchaud,et al.  Conditions for maximal synthesis of cyclic AMP by mouse macrophages in response to β‐adrenergic stimulation , 1978, European journal of immunology.

[68]  J. Darnell,et al.  5,6-Dichloro-1-Beta-D-ribofuranosylbenzimidazole inhibits initiation of nuclear heterogeneous RNA chains in HeLa cells. , 1976, Science.

[69]  H. Bourne,et al.  Modulation of Inflammation and Immunity by Cyclic AMP , 1974 .

[70]  R. Tapping,et al.  Roles for LBP and soluble CD14 in cellular uptake of LPS. , 1998, Progress in clinical and biological research.

[71]  J. Habener,et al.  Cyclic AMP signaling and gene regulation. , 1998, Annual review of nutrition.

[72]  A. DeFranco,et al.  The role of tyrosine kinases and map kinases in LPS-induced signaling. , 1998, Progress in clinical and biological research.

[73]  M. Fieren.  Mechanisms regulating cytokine release from peritoneal macrophages during continuous ambulatory peritoneal dialysis. , 1996, Blood purification.

[74]  I. Bonta,et al.  Prostaglandin E2 inhibits the release of tumor necrosis factor-alpha, rather than interleukin 1 beta, from human macrophages. , 1992, Immunology letters.

[75]  J. Strominger,et al.  Biochemical characterization of a soluble form of the 53‐kDa monocyte surface antigen , 1986, European journal of immunology.